iXensor’s newly launched product, PixoTest® COVID -19 Antigen Self-Test Kit, could detect the COVID -19 major strain Omicron BA.5, combining the self-reporting function of PixoHealth App, leading to a safe, secured, and protected social new normal

iXensor, the pioneer of mobile health, today announced its “PixoTest® COVID -19 Antigen Self-Test Kit” has been granted by Taiwan FDA for EUA, in response to the recent peak of the epidemic and the new quarantine mandate of 0+7 taking effect on Oct 13th, Taiwan will officially enter the era…

read more

iXensor Receives Strategic Investment from Rohto Pharmaceutical with A Separate Technology Licensing Agreement

PixoTech® licensing shifted in as iXensor’s new growth engine to meet self-testing strong demand in the post-pandemic era Taipei, Taiwan / Osaka, Japan, April 27th, 2022 – iXensor Co., Ltd. (6734. TWO) iXensor, the pioneer of mobile health, today announced that Rohto Pharmaceutical Co., Ltd, a multinational pharmaceutical corporation headquartered in Japan, has…

read more

iXensor’s Eveline·Care telehealth empowering fertility services to assist patients’ conceptions with at-home test monitoring

Palo Alto, California / Taipei, Taiwan, September 14th, 2021 – iXensor Co., Ltd. (6734.TWO) iXensor, the pioneer of mobile health, launches its new Eveline·Care service, effectively turning the smartphone-based Eveline Ovulation Predictor Kit (OPK) into a telehealth-enabled fertility monitoring system. This telehealth service is anticipated by OB-GYN practitioners and highly…

read more

iXensor levels up PixoTest® COVID-19 Ag Test with the launch of PixoHealth data management platform as the security solution for the new normalcy

PixoHealth Pass Admin App and Web Portal empowers safer reopening in the post-pandemic era

The GDPR-compliant PixoHealth Pass Admin Solution works with PixoTest® POCT COVID-19 Antigen Test to help organizations maintain COVID-19 free environments The PixoTest® POCT COVID-19 Antigen Test detects the key SARS-CoV-2 variants, including Alpha, Beta, Gamma and Delta Connected point-of-care screening is the critical security mechanism of the post-pandemic normalcy  …

read more

iXensor Launches CE-marked Fully Digitized PixoTest COVID-19 Rapid Test with Digital Health Pass to Facilitate Safe Reopening of Economies

iXensor launches CE marked PixoTest COVID-19 Antigen Test

iXensor, the pioneer of mobile health, announces today that its PixoTest® POCT COVID-19 Antigen Test has received the CE-IVD mark. iXensor provides the end-to-end fully digitalized solution to prevent further outbreaks. iXensor’s PixoTest® solution comprises a palm-sized analyzer that reads test results accurately, a digital health pass App, an Admin…

read more